SPAGGIARI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.953
AS - Asia 1.548
EU - Europa 1.176
SA - Sud America 247
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 13
Totale 5.018
Nazione #
US - Stati Uniti d'America 1.841
IT - Italia 674
CN - Cina 437
SG - Singapore 428
BR - Brasile 162
VN - Vietnam 159
HK - Hong Kong 157
GB - Regno Unito 86
DE - Germania 78
BD - Bangladesh 69
KR - Corea 64
RU - Federazione Russa 62
IN - India 61
SE - Svezia 45
FI - Finlandia 39
MX - Messico 35
CA - Canada 34
AR - Argentina 33
ID - Indonesia 33
FR - Francia 28
NL - Olanda 23
EC - Ecuador 22
HU - Ungheria 20
IQ - Iraq 20
AT - Austria 17
TR - Turchia 15
JP - Giappone 14
LT - Lituania 14
MY - Malesia 14
PL - Polonia 14
PK - Pakistan 13
AU - Australia 11
PT - Portogallo 11
ZA - Sudafrica 11
CO - Colombia 10
ES - Italia 10
AE - Emirati Arabi Uniti 9
TT - Trinidad e Tobago 9
CR - Costa Rica 8
IL - Israele 8
MA - Marocco 8
UA - Ucraina 8
UZ - Uzbekistan 8
BG - Bulgaria 7
CL - Cile 7
CZ - Repubblica Ceca 7
EG - Egitto 7
NP - Nepal 7
TH - Thailandia 7
BE - Belgio 6
GT - Guatemala 6
PH - Filippine 5
PY - Paraguay 5
SV - El Salvador 5
VE - Venezuela 5
DZ - Algeria 4
GP - Guadalupe 4
GR - Grecia 4
IE - Irlanda 4
MT - Malta 4
RO - Romania 4
CH - Svizzera 3
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
EE - Estonia 3
IR - Iran 3
JM - Giamaica 3
JO - Giordania 3
NI - Nicaragua 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
LK - Sri Lanka 2
PE - Perù 2
SC - Seychelles 2
BJ - Benin 1
CD - Congo 1
CG - Congo 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UG - Uganda 1
Totale 4.985
Città #
Singapore 287
Ashburn 252
Santa Clara 221
San Jose 204
Hefei 195
Council Bluffs 163
Hong Kong 136
Modena 88
New York 64
Seoul 62
Bologna 61
Los Angeles 60
Dallas 59
Beijing 57
Ho Chi Minh City 56
Carpi 51
London 39
Hanoi 35
Milan 34
Reggio Emilia 32
Chandler 30
Chicago 28
Jakarta 26
Rome 24
Parma 21
Buffalo 18
Helsinki 18
São Paulo 18
The Dalles 18
Munich 17
Nyköping 17
Haiphong 16
Mexico City 16
Nuremberg 16
Chennai 15
Orem 15
Szeged 15
Trieste 14
Kent 13
Lauterbourg 13
Montreal 13
Moscow 13
Tokyo 13
Lappeenranta 12
Denver 11
Naples 11
Poplar 11
Warsaw 11
Atlanta 10
Boardman 10
Central 10
Houston 10
Baghdad 9
Brooklyn 9
Florence 9
Frankfurt am Main 9
Guangzhou 9
Perugia 9
Roteglia 9
Stockholm 9
Tiruchirappalli 9
Turku 9
Amsterdam 8
Boston 8
Guayaquil 8
Johannesburg 8
Mumbai 8
San Francisco 8
San José 8
Vienna 8
Islamabad 7
Miami 7
Quito 7
Seattle 7
Somerville 7
Tashkent 7
Ankara 6
Bangkok 6
Da Nang 6
Garner 6
Honolulu 6
Kuala Lumpur 6
Memphis 6
North Bergen 6
Padova 6
Phoenix 6
Piscataway 6
Sai Kung 6
Bogotá 5
Buenos Aires 5
Casablanca 5
Erbil 5
Falkenstein 5
Fidenza 5
Guatemala City 5
Manchester 5
Monza 5
San Martino in Rio 5
San Salvador 5
Shanghai 5
Totale 2.987
Nome #
Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro 421
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 377
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 371
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 341
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 338
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 303
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 267
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus, Lactobacillus (L.) acidophilus, Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus 261
THE PROTECTIVE ROLE OF TYPE-I INTERFERONS AXIS ACTIVATION IN THE VULVOVAGINAL CANDIDIASIS MODEL 239
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro 237
Candidalysin is a key player in activating vaginal cell ROS in an in vitro infection model 207
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity 199
The pathogenic and colonization potential of Candida africana 195
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 194
Biological Features, Antimicrobial Susceptibility and Phenotypic Characterization of Candidozyma auris CDC B11903 Grown at Different Temperatures 193
In vivo colonization and pathogenic potential of C. africana 192
The protective role of type I interferon pathway activation in an in vitro model of vulvovaginal candidiasis 166
The Community State Type I dominated by Lactobacillus crispatus is the most effective vaginal microbiota in counteracting Candida albicans infection in vitro 126
Differential modulation of complosome by colonizing and VVC-associated Candida (C.) albicans strains in vaginal epithelial cells 99
Vaginal clinical isolates of Candida albicans differentially modulate type I interferon pathway in an in vitro infection model 97
Prophylactic Potential of Heyndrickxia coagulans Strain LMG S-24828 in an In Vitro Model of ESBL–Escherichia coli Urothelial Infection 53
Untargeted Metabolomic Analysis of Cell-Free Supernatants (CFSs) from Different Clinical Isolates of Saccharomyces cerevisiae and Their Effects on Candida albicans Virulence 51
Is immunotherapy safe and effective in patients with VEXAS syndrome? 51
Differential Virulence of Vaginal Candida albicans IsolatesC orrelates with Host Inflammatory Responses in VVC/RVVC 40
Totale 5.018
Categoria #
all - tutte 16.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202272 0 0 0 0 5 5 5 2 7 0 27 21
2022/2023333 6 11 21 20 31 53 19 45 46 26 30 25
2023/2024373 14 16 36 26 42 47 37 17 27 43 32 36
2024/20251.043 15 25 30 76 166 152 76 76 95 73 98 161
2025/20262.391 154 139 164 369 346 160 242 125 199 249 163 81
2026/2027777 95 176 195 250 61 0 0 0 0 0 0 0
Totale 5.018